Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI20101079 |
Pages: 310 |
Sep 2024 |
The skin grafts market was valued at $4.92 billion in 2023 and is estimated to reach $9.25 billion by 2033, exhibiting a CAGR of 7.0% from 2024 to 2032.
Skin grafts are a medical procedure in which skin is transplanted from one area of the body to another. This technique is commonly used to treat extensive wounds, burns, or areas of skin loss due to injury or surgery. The procedure helps to close wounds, reduce the risk of infection, and improve the appearance of the affected area. There are two main types of skin grafts: split-thickness and full-thickness. Split-thickness grafts involve removing the top layers of skin (epidermis and part of the dermis) from a donor site, typically an area that can heal easily such as the thigh or buttocks. These grafts are often used for larger wound areas and heal quickly, but they may not provide the same cosmetic results as full-thickness grafts.
Full-thickness grafts, on the other hand, involve removing all the layers of skin, including the epidermis and entire dermis, from the donor site. These grafts are usually employed for smaller wound areas where a better cosmetic result is desired, such as on the face. However, full-thickness grafts require more meticulous surgical techniques and longer healing times at the donor site.
The increasing number of surgical procedures significantly drives the growth of the skin grafts market. Reconstructive surgeries often follow traumatic injuries, cancer treatments, or severe infections, where skin grafts are essential for repairing and restoring damaged skin. The rise in such surgeries, driven by improved surgical techniques and better healthcare access, directly boosts the demand for skin grafts. Cosmetic surgeries, including facelifts, tummy tucks, and body contouring, sometimes require skin grafts to achieve optimal aesthetic outcomes. The increasing societal acceptance of cosmetic procedures, along with advancements in surgical techniques, has led to a rise in the number of these surgeries, thereby increasing the demand for skin grafts.
Skin grafting procedures can be expensive, considering the costs of surgery, hospitalization, post-operative care, and rehabilitation. These high costs can be prohibitive for many patients, especially in low- and middle-income countries, thereby limiting market growth. Skin grafting surgeries carry risks of complications such as graft rejection, infections, scarring, and graft failure. These potential adverse outcomes can deter patients and healthcare providers from opting for skin grafts, thus restraining market growth.
Continued advancements in medical technology, including the development of novel biomaterials, tissue engineering techniques, and 3D printing, present opportunities for innovation in skin grafts. These technological advancements can lead to the creation of more effective and versatile grafting solutions, catering to a broader range of patient needs. The field of regenerative medicine holds promise for revolutionizing skin grafting procedures. Stem cell therapies, growth factors, and tissue engineering approaches offer opportunities to enhance the regenerative capacity of skin grafts, promoting faster wound healing and improved outcomes for patients.
On December 21, 2023, a patent application was filed by King Abdullah University of Science and Technology with the United States of America office for a novel development in the field of tissue engineering and regenerative medicine. The application details the creation of ultrashort tetrameric peptide nanogels, which have shown significant potential in supporting tissue graft formation, wound healing, and 3D bioprinting.
These newly developed peptide nanogels provide essential native cues to human dermal fibroblasts and mouse myoblast cells, promoting their proliferation and extensive network formation in vitro. This advancement represents a significant improvement in the fabrication of dermal grafts and 3D skin models. Importantly, when applied to full-thickness wounds in a minipig model, the peptide nanogels demonstrated biocompatibility with the minipig skin tissue, as they did not induce wound inflammation. This finding suggests that these peptide nanogels are a safe biomaterial for topical applications.
Additionally, the research highlights the printable nature of these peptides. The successful printing and the high cell viability within the printed constructs pave the way for the 3D bioprinting of various cell types in the future. This capability could revolutionize tissue engineering by enabling the creation of complex tissue structures tailored to individual patient needs.
The skin grafts market is segmented into graft type, graft thickness, applications, equipment, end users and region. On the basis of graft type, the market is divided into autologous, isogeneic, allogeneic, xenogeneic, and prosthetic. On the basis of graft thickness, the market is divided into split-thickness, full-thickness, and composite graft. On the basis of applications, the market is divided into extensive wound, burns, extensive skin loss due to infection, skin cancers, and others. On the basis of equipment, the market is divided into dermatome, general surgical instruments, consumables, and others. On the basis of end users, the market is divided into hospitals and clinics, academic and research, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The skin grafts market in the Asia-Pacific region is projected to show the fastest growth during the forecast period. The surge in burn incidents within developing nations such as India, Malaysia, and Indonesia is a significant contributor to this trend. The aging population in many Asia-Pacific countries has led to a higher prevalence of chronic wounds, ulcers, and other skin conditions, driving the demand for skin grafting procedures. Increasing disposable income and healthcare spending in countries like China, India, and Southeast Asian nations have facilitated the adoption of advanced medical treatments, including skin grafts. .
Additionally, the skin graft market in China dominated with the largest market share in 2023, while India's skin graft market exhibited the most rapid growth in the Asia-Pacific region.
The major players operating in the skin grafts market include Zimmer Biomet, B. Braun Melsungen AG, Avita Medical, Integra Lifesciences Corporation, Surtex Instruments Limited, Nouvag AG, MiMedx, Organogenesis Inc., De Soutter Medical Limited, and Tissue Regenix.
The report includes the analysis of the regional as well as skin grafts market trends, key players, market segments, application areas, and market growth strategies.
Aspect | Particulars |
Historical Market Estimations | 2021-2022 |
Base Year for Market Estimation | 2023 |
Forecast Timeline for Market Projection | 2024-2033 |
Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
Segmentation by Graft Type |
|
Segmentation by Graft Thickness |
|
Segmentation by Applications |
|
Segmentation by Equipment |
|
Segmentation by End user |
|
Key Companies Profiled |
|
1. Research Methodology
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
2. Report Scope
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on global Skin Grafts Market
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Legal
4.6.6. Environmental
4.7. Impact of COVID-19 on Skin Grafts Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
5. Skin Grafts Market Analysis, by Graft Type
5.1. Overview
5.2. Autologous
5.2.1. Definition, key trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2023-2033
5.2.3. Market share analysis, by country, 2023-2033
5.3. Isogeneic
5.3.1. Definition, key trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2023-2033
5.3.3. Market share analysis, by country, 2023-2033
5.4. Allogeneic
5.4.1. Definition, key trends, growth factors, and opportunities
5.4.2. Market size analysis, by region, 2023-2033
5.4.3. Market share analysis, by country, 2023-2033
5.5. Xenogeneic
5.5.1. Definition, key trends, growth factors, and opportunities
5.5.2. Market size analysis, by region, 2023-2033
5.5.3. Market share analysis, by country, 2023-2033
5.6. Prosthetic
5.6.1. Definition, key trends, growth factors, and opportunities
5.6.2. Market size analysis, by region, 2023-2033
5.6.3. Market share analysis, by country, 2023-2033
5.7. Research Dive Exclusive Insights
5.7.1. Market attractiveness
5.7.2. Competition heatmap
6. Skin Grafts Market Analysis, by Graft Thickness
6.1. Overview
6.2. Split-Thickness
6.2.1. Definition, key trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2023-2033
6.2.3. Market share analysis, by country, 2023-2033
6.3. Full-Thickness
6.3.1. Definition, key trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2023-2033
6.3.3. Market share analysis, by country, 2023-2033
6.4. Composite Graft
6.4.1. Definition, key trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2023-2033
6.4.3. Market share analysis, by country, 2023-2033
6.5. Research Dive Exclusive Insights
6.5.1. Market attractiveness
6.5.2. Competition heatmap
7. Skin Grafts Market Analysis, by Applications
7.1. Overview
7.2. Extensive Wound
7.2.1. Definition, key trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2023-2033
7.2.3. Market share analysis, by country, 2023-2033
7.3. Burns
7.3.1. Definition, key trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2023-2033
7.3.3. Market share analysis, by country, 2023-2033
7.4. Extensive Skin Loss Due to Infection
7.4.1. Definition, key trends, growth factors, and opportunities
7.4.2. Market size analysis, by region, 2023-2033
7.4.3. Market share analysis, by country, 2023-2033
7.5. Skin Cancers
7.5.1. Definition, key trends, growth factors, and opportunities
7.5.2. Market size analysis, by region, 2023-2033
7.5.3. Market share analysis, by country, 2023-2033
7.6. Others
7.6.1. Definition, key trends, growth factors, and opportunities
7.6.2. Market size analysis, by region, 2023-2033
7.6.3. Market share analysis, by country, 2023-2033
7.7. Research Dive Exclusive Insights
7.7.1. Market attractiveness
7.7.2. Competition heatmap
8. Skin Grafts Market Analysis, by Equipment
8.1. Overview
8.2. Dermatome
8.2.1. Definition, key trends, growth factors, and opportunities
8.2.2. Market size analysis, by region, 2023-2033
8.2.3. Market share analysis, by country, 2023-2033
8.3. General Surgical Instruments
8.3.1. Definition, key trends, growth factors, and opportunities
8.3.2. Market size analysis, by region, 2023-2033
8.3.3. Market share analysis, by country, 2023-2033
8.4. Consumables
8.4.1. Definition, key trends, growth factors, and opportunities
8.4.2. Market size analysis, by region, 2023-2033
8.4.3. Market share analysis, by country, 2023-2033
8.5. Others
8.5.1. Definition, key trends, growth factors, and opportunities
8.5.2. Market size analysis, by region, 2023-2033
8.5.3. Market share analysis, by country, 2023-2033
8.6. Research Dive Exclusive Insights
8.6.1. Market attractiveness
8.6.2. Competition heatmap
9. Skin Grafts Market Analysis, by End Users
9.1. Overview
9.2. Hospitals and Clinics
9.2.1. Definition, key trends, growth factors, and opportunities
9.2.2. Market size analysis, by region, 2023-2033
9.2.3. Market share analysis, by country, 2023-2033
9.3. Academic and Research
9.3.1. Definition, key trends, growth factors, and opportunities
9.3.2. Market size analysis, by region, 2023-2033
9.3.3. Market share analysis, by country, 2023-2033
9.4. Others
9.4.1. Definition, key trends, growth factors, and opportunities
9.4.2. Market size analysis, by region, 2023-2033
9.4.3. Market share analysis, by country, 2023-2033
9.5. Research Dive Exclusive Insights
9.5.1. Market attractiveness
9.5.2. Competition heatmap
10. Skin Grafts Market, by Region
10.1. North America
10.1.1. U.S.
10.1.1.1. Market size analysis, by Graft Type, 2023-2033
10.1.1.2. Market size analysis, by Graft Thickness, 2023-2033
10.1.1.3. Market size analysis, by Applications, 2023-2033
10.1.1.4. Market size analysis, by Equipment, 2023-2033
10.1.1.5. Market size analysis, by End User, 2023-2033
10.1.2. Canada
10.1.2.1. Market size analysis, by Graft Type, 2023-2033
10.1.2.2. Market size analysis, by Graft Thickness, 2023-2033
10.1.2.3. Market size analysis, by Applications, 2023-2033
10.1.2.4. Market size analysis, by Equipment, 2023-2033
10.1.2.5. Market size analysis, by End User, 2023-2033
10.1.3. Mexico
10.1.3.1. Market size analysis, by Graft Type, 2023-2033
10.1.3.2. Market size analysis, by Graft Thickness, 2023-2033
10.1.3.3. Market size analysis, by Applications, 2023-2033
10.1.3.4. Market size analysis, by Equipment, 2023-2033
10.1.3.5. Market size analysis, by End User, 2023-2033
10.1.4. Research Dive Exclusive Insights
10.1.4.1. Market attractiveness
10.1.4.2. Competition heatmap
10.2. Europe
10.2.1. Germany
10.2.1.1. Market size analysis, by Graft Type, 2023-2033
10.2.1.2. Market size analysis, by Graft Thickness, 2023-2033
10.2.1.3. Market size analysis, by Applications, 2023-2033
10.2.1.4. Market size analysis, by Equipment, 2023-2033
10.2.1.5. Market size analysis, by End User, 2023-2033
10.2.2. UK
10.2.2.1. Market size analysis, by Graft Type, 2023-2033
10.2.2.2. Market size analysis, by Graft Thickness, 2023-2033
10.2.2.3. Market size analysis, by Applications, 2023-2033
10.2.2.4. Market size analysis, by Equipment, 2023-2033
10.2.2.5. Market size analysis, by End User, 2023-2033
10.2.3. France
10.2.3.1. Market size analysis, by Graft Type, 2023-2033
10.2.3.2. Market size analysis, by Graft Thickness, 2023-2033
10.2.3.3. Market size analysis, by Applications, 2023-2033
10.2.3.4. Market size analysis, by Equipment, 2023-2033
10.2.3.5. Market size analysis, by End User, 2023-2033
10.2.4. Spain
10.2.4.1. Market size analysis, by Graft Type, 2023-2033
10.2.4.2. Market size analysis, by Graft Thickness, 2023-2033
10.2.4.3. Market size analysis, by Applications, 2023-2033
10.2.4.4. Market size analysis, by Equipment, 2023-2033
10.2.4.5. Market size analysis, by End User, 2023-2033
10.2.5. Italy
10.2.5.1. Market size analysis, by Graft Type, 2023-2033
10.2.5.2. Market size analysis, by Graft Thickness, 2023-2033
10.2.5.3. Market size analysis, by Applications, 2023-2033
10.2.5.4. Market size analysis, by Equipment, 2023-2033
10.2.5.5. Market size analysis, by End User, 2023-2033
10.2.6. Rest of Europe
10.2.6.1. Market size analysis, by Graft Type, 2023-2033
10.2.6.2. Market size analysis, by Graft Thickness, 2023-2033
10.2.6.3. Market size analysis, by Applications, 2023-2033
10.2.6.4. Market size analysis, by Equipment, 2023-2033
10.2.6.5. Market size analysis, by End User, 2023-2033
10.2.7. Research Dive Exclusive Insights
10.2.7.1. Market attractiveness
10.2.7.2. Competition heatmap
10.3. Asia-Pacific
10.3.1. China
10.3.1.1. Market size analysis, by Graft Type, 2023-2033
10.3.1.2. Market size analysis, by Graft Thickness, 2023-2033
10.3.1.3. Market size analysis, by Applications, 2023-2033
10.3.1.4. Market size analysis, by Equipment, 2023-2033
10.3.1.5. Market size analysis, by End User, 2023-2033
10.3.2. Japan
10.3.2.1. Market size analysis, by Graft Type, 2023-2033
10.3.2.2. Market size analysis, by Graft Thickness, 2023-2033
10.3.2.3. Market size analysis, by Applications, 2023-2033
10.3.2.4. Market size analysis, by Equipment, 2023-2033
10.3.2.5. Market size analysis, by End User, 2023-2033
10.3.3. India
10.3.3.1. Market size analysis, by Graft Type, 2023-2033
10.3.3.2. Market size analysis, by Graft Thickness, 2023-2033
10.3.3.3. Market size analysis, by Applications, 2023-2033
10.3.3.4. Market size analysis, by Equipment, 2023-2033
10.3.3.5. Market size analysis, by End User, 2023-2033
10.3.4. Australia
10.3.4.1. Market size analysis, by Graft Type, 2023-2033
10.3.4.2. Market size analysis, by Graft Thickness, 2023-2033
10.3.4.3. Market size analysis, by Applications, 2023-2033
10.3.4.4. Market size analysis, by Equipment, 2023-2033
10.3.4.5. Market size analysis, by End User, 2023-2033
10.3.5. South Korea
10.3.5.1. Market size analysis, by Graft Type, 2023-2033
10.3.5.2. Market size analysis, by Graft Thickness, 2023-2033
10.3.5.3. Market size analysis, by Applications, 2023-2033
10.3.5.4. Market size analysis, by Equipment, 2023-2033
10.3.5.5. Market size analysis, by End User, 2023-2033
10.3.6. Rest of Asia-Pacific
10.3.6.1. Market size analysis, by Graft Type, 2023-2033
10.3.6.2. Market size analysis, by Graft Thickness, 2023-2033
10.3.6.3. Market size analysis, by Applications, 2023-2033
10.3.6.4. Market size analysis, by Equipment, 2023-2033
10.3.6.5. Market size analysis, by End User, 2023-2033
10.3.7. Research Dive Exclusive Insights
10.3.7.1. Market attractiveness
10.3.7.2. Competition heatmap
10.4. LAMEA
10.4.1. Brazil
10.4.1.1. Market size analysis, by Graft Type, 2023-2033
10.4.1.2. Market size analysis, by Graft Thickness, 2023-2033
10.4.1.3. Market size analysis, by Applications, 2023-2033
10.4.1.4. Market size analysis, by Equipment, 2023-2033
10.4.1.5. Market size analysis, by End User, 2023-2033
10.4.2. Saudi Arabia
10.4.2.1. Market size analysis, by Graft Type, 2023-2033
10.4.2.2. Market size analysis, by Graft Thickness, 2023-2033
10.4.2.3. Market size analysis, by Applications, 2023-2033
10.4.2.4. Market size analysis, by Equipment, 2023-2033
10.4.2.5. Market size analysis, by End User, 2023-2033
10.4.3. UAE
10.4.3.1. Market size analysis, by Graft Type, 2023-2033
10.4.3.2. Market size analysis, by Graft Thickness, 2023-2033
10.4.3.3. Market size analysis, by Applications, 2023-2033
10.4.3.4. Market size analysis, by Equipment, 2023-2033
10.4.3.5. Market size analysis, by End User, 2023-2033
10.4.4. South Africa
10.4.4.1. Market size analysis, by Graft Type, 2023-2033
10.4.4.2. Market size analysis, by Graft Thickness, 2023-2033
10.4.4.3. Market size analysis, by Applications, 2023-2033
10.4.4.4. Market size analysis, by Equipment, 2023-2033
10.4.4.5. Market size analysis, by End User, 2023-2033
10.4.5. Rest of LAMEA
10.4.5.1. Market size analysis, by Graft Type, 2023-2033
10.4.5.2. Market size analysis, by Graft Thickness, 2023-2033
10.4.5.3. Market size analysis, by Applications, 2023-2033
10.4.5.4. Market size analysis, by Equipment, 2023-2033
10.4.5.5. Market size analysis, by End User, 2023-2033
10.4.6. Research Dive Exclusive Insights
10.4.6.1. Market attractiveness
10.4.6.2. Competition heatmap
11. Competitive Landscape
11.1. Top winning strategies, 2022
11.1.1. By strategy
11.1.2. By year
11.2. Strategic overview
11.3. Market share analysis, 2023
12. Company Profiles
12.1. Zimmer Biomet
12.1.1. Overview
12.1.2. Business segments
12.1.3. Product portfolio
12.1.4. Financial performance
12.1.5. Recent developments
12.1.6. SWOT analysis
12.2. B. Braun Melsungen AG
12.2.1. Overview
12.2.2. Business segments
12.2.3. Product portfolio
12.2.4. Financial performance
12.2.5. Recent developments
12.2.6. SWOT analysis
12.3. Avita Medical
12.3.1. Overview
12.3.2. Business segments
12.3.3. Product portfolio
12.3.4. Financial performance
12.3.5. Recent developments
12.3.6. SWOT analysis
12.4. Integra Lifesciences Corporation
12.4.1. Overview
12.4.2. Business segments
12.4.3. Product portfolio
12.4.4. Financial performance
12.4.5. Recent developments
12.4.6. SWOT analysis
12.5. Surtex Instruments Limited
12.5.1. Overview
12.5.2. Business segments
12.5.3. Product portfolio
12.5.4. Financial performance
12.5.5. Recent developments
12.5.6. SWOT analysis
12.6. Nouvag AG
12.6.1. Overview
12.6.2. Business segments
12.6.3. Product portfolio
12.6.4. Financial performance
12.6.5. Recent developments
12.6.6. SWOT analysis
12.7. MiMedx
12.7.1. Overview
12.7.2. Business segments
12.7.3. Product portfolio
12.7.4. Financial performance
12.7.5. Recent developments
12.7.6. SWOT analysis
12.8. Organogenesis Inc.
12.8.1. Overview
12.8.2. Business segments
12.8.3. Product portfolio
12.8.4. Financial performance
12.8.5. Recent developments
12.8.6. SWOT analysis
12.9. De Soutter Medical Limited
12.9.1. Overview
12.9.2. Business segments
12.9.3. Product portfolio
12.9.4. Financial performance
12.9.5. Recent developments
12.9.6. SWOT analysis
12.10. Tissue Regenix
12.10.1. Overview
12.10.2. Business segments
12.10.3. Product portfolio
12.10.4. Financial performance
12.10.5. Recent developments
12.10.6. SWOT analysis
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization